Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

BICYCLE THERAPEUTICS PLC

BCYC · Nasdaq · CIK 0001761612 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

23 Form 4 transaction lines observed in the same window
23 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2024-12-16 · 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP · $7.7M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Perry Jennifer ScottChief Operating Officer
▼▼▼▼
Skynner MichaelCHIEF SCIENTIFIC OFFICER
▼▼▼▼
Lee KevinCHIEF EXECUTIVE OFFICER
▼▼▼▼
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
▼▼▼▼
Thompson Travis AlvinChief Financial Officer
▼▼▼▼
Swanton Robert CharlesDirector
▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-12-16 · 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP.

Recent Form 4 activity

0Purchases
47Sales
15Other Form 4 lines
31SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING23 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-6.0%
3M
-16.8%
6M
-35.1%
12M
-58.8%

Volatility & liquidity

Volatility
60.4%
Beta
—
Avg daily value
USD 1.4M

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-301.7%
ROE
-35.9%
Industry
Biotechnology

Market data

Price data up to: 2026-10-16 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
3,302,888
Previous report
3,331,791
Avg daily volume
378,570
Days to cover
8.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-12-16667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)American Depositary Shares500,000USD 15.34USD 7,670,000SEC filing ↗
2024-12-13667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LPPurchase (P)American Depositary Shares985,397USD 13.76USD 13,556,032SEC filing ↗

Form 4 evidence

62 transaction lines in the latest 365-day window; 393 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Thompson Travis AlvinSale (S)Ordinary Shares79USD 3.57USD 282SEC filing ↗
2026-10-05Skynner MichaelSale (S)Ordinary Shares503USD 3.57USD 1,796SEC filing ↗
2026-10-05Perry Jennifer ScottSale (S)Ordinary Shares406USD 3.74USD 1,517SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Thompson Travis AlvinSale (S)Ordinary Shares79USD 3.57USD 282SEC filing ↗
2026-10-05Skynner MichaelSale (S)Ordinary Shares503USD 3.57USD 1,796SEC filing ↗
2026-10-05Perry Jennifer ScottSale (S)Ordinary Shares406USD 3.74USD 1,517SEC filing ↗
2026-10-05Lee KevinSale (S)Ordinary Shares1,638USD 3.57USD 5,848SEC filing ↗
2026-10-05Hannay Michael Charles FergusonSale (S)Ordinary Shares242USD 3.57USD 864SEC filing ↗
2026-10-02Thompson Travis AlvinSale (S)Ordinary Shares893USD 3.47USD 3,099SEC filing ↗
2026-10-02Swanton Robert CharlesSale (S)Ordinary Shares3,431USD 3.47USD 11,906SEC filing ↗
2026-10-02Skynner MichaelSale (S)Ordinary Shares1,942USD 3.47USD 6,739SEC filing ↗
2026-10-02Perry Jennifer ScottSale (S)Ordinary Shares1,094USD 3.47USD 3,796SEC filing ↗
2026-10-02Lee KevinSale (S)Ordinary Shares6,167USD 3.47USD 21,399SEC filing ↗
2026-10-02Hannay Michael Charles FergusonSale (S)Ordinary Shares1,572USD 3.47USD 5,455SEC filing ↗
2026-07-06Thompson Travis AlvinSale (S)Ordinary Shares104USD 4.31USD 448SEC filing ↗
2026-07-06Skynner MichaelSale (S)Ordinary Shares532USD 4.31USD 2,293SEC filing ↗
2026-07-06Perry Jennifer ScottSale (S)Ordinary Shares376USD 4.34USD 1,631SEC filing ↗
2026-07-06Lee KevinSale (S)Ordinary Shares1,737USD 4.31USD 7,486SEC filing ↗
2026-07-06Hannay Michael Charles FergusonSale (S)Ordinary Shares255USD 4.31USD 1,099SEC filing ↗
2026-07-02Thompson Travis AlvinSale (S)Ordinary Shares819USD 4.27USD 3,497SEC filing ↗
2026-07-02Skynner MichaelSale (S)Ordinary Shares1,859USD 4.27USD 7,938SEC filing ↗
2026-07-02Perry Jennifer ScottSale (S)Ordinary Shares1,036USD 4.27USD 4,424SEC filing ↗
2026-07-02Lee KevinSale (S)Ordinary Shares5,905USD 4.27USD 25,214SEC filing ↗
2026-07-02Hannay Michael Charles FergusonSale (S)Ordinary Shares1,506USD 4.27USD 6,431SEC filing ↗
2026-04-06Thompson Travis AlvinSale (S)Ordinary Shares102USD 5.05USD 515SEC filing ↗
2026-04-06Skynner MichaelSale (S)Ordinary Shares525USD 5.05USD 2,651SEC filing ↗
2026-04-06Perry Jennifer ScottSale (S)Ordinary Shares370USD 5.04USD 1,865SEC filing ↗
2026-04-06Lee KevinSale (S)Ordinary Shares1,716USD 5.05USD 8,666SEC filing ↗
2026-04-06Hannay Michael Charles FergusonSale (S)Ordinary Shares251USD 5.05USD 1,268SEC filing ↗
2026-04-02Thompson Travis AlvinSale (S)Ordinary Shares799USD 4.91USD 3,923SEC filing ↗
2026-04-02Skynner MichaelSale (S)Ordinary Shares1,879USD 4.91USD 9,226SEC filing ↗
2026-04-02Perry Jennifer ScottSale (S)Ordinary Shares1,038USD 4.91USD 5,097SEC filing ↗
2026-04-02Lee KevinSale (S)Ordinary Shares5,967USD 4.91USD 29,298SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerBCYC
CIK0001761612
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history393 transaction lines from 2020-04-14 to 2026-10-05
10 P purchase lines · 252 S sale lines · 131 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.